Broker Tips
Analysts have mixed feelings on Barclays 'messy' results
On the face of it, Barclays' first-half results beat City consensus forecasts but analysts had mixed feelings after digging deeper into the numbers.
Friday broker round-up
AstraZeneca: Morgan Stanley downgrades to Equal Weight with a target price of 4700p.
Morgan Stanley downgrades AstraZeneca after failed drug trial
Morgan Stanley downgraded its stance on AstraZeneca to 'equalweight' from 'overweight' and cut the price target to 4,700p from 5,600p after the pharmaceutical giant said on Thursday that initial results from its Mystic lung cancer drug trial failed to meet primary endpoints.
Credit Suisse hails Compass's outlook in US, cash return potential
Credit Suisse bumped up its target price on Compass's shares, highlighting the company's strong organic growth in developed markets, especially in the US.
Citi stays at 'sell' on Fresnillo ahead of 1H numbers
Analysts at Citi stuck by their 'sell' recommendation on Fresnillo stock, pointing to the shares' "expensive" valuation and inability to boost cash returns beyond the "normal" payout.
Wednesday broker round-up
Acacia Mining: Credit Suisse downgrades to Neutral with a target price of 200p.
Rumours of Asda takeover of B&M European have 'little logic'
On the back of rumours suggesting discount retailer B&M European Value was a takeover target for Asda, analysts at Investec poured scorn on there being much logic in such a deal but still like the look of the company.
Monday broker round-up
Sports Direct: Goldman Sachs upgrades to Neutral with a target price of 350p.
RBC Capital double upgrades Drax to 'outperform'
RBC Capital Markets upgraded Drax to 'outperform' from 'underperform' and lifted the price target to 400p from 340p.
Goldman ups Sports Direct to 'neutral'
Goldman Sachs upgraded Sports Direct International to 'neutral' as it removed the stock from its Sell list and lifted the price target to 350p from 260p, saying a stable FY18 pre-tax profit and the share buyback should drive a return to earnings per share growth.
Broker tips: Paddy Power Betfair, Equiniti
Paddy Power Betfair lost ground on Friday as Investec downgraded its stance on the stock to 'sell' from 'buy' and cut the price target to 6,970p from 10,000p on the back of lower forecasts and a deteriorating regulatory outlook in the UK and Australia.
Goldman Sachs raises Equiniti target on US expansion
Analysts at Citi bumped up their target price for shares of Equiniti, hailing its acquisition of Wells Fargo Share Registration & Services.
Citi gives Microsoft a $74 price target
After a callback from Microsoft, Citi has slapped a 'neutral' rating on the tech stock and a target price of $74, slightly below its current price as it does not expect a significant impact from the new Xbox console update.
Wednesday broker round-up
Direct Line: Credit Suisse upgrades to Outperform with a target price of 410p.
Investec downgrades Paddy Power on worsening regulatory outlook
Paddy Power Betfair lost ground on Friday as Investec downgraded its stance on the stock to ‘sell’ from ‘buy’ and cut the price target to 6,970p from 10,000p on the back of lower forecasts and a deteriorating regulatory outlook in the UK and Australia.
Citigroup downgrades BHP Billiton on oil price headwinds
Mining firm BHP Billiton saw its stock rating downgraded to ‘neutral’ by Citigroup on Thursday following the release of its annual production this week.
Thursday broker round-up
BHP Billiton: Citigroup downgrades to Neutral with a target price of 1350p.